An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study-Reference-Cited by-同舟云学术

An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study

Published:2007-05-31 Issue:1 Volume:7 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Manolakopoulos Spilios,Bethanis Sotirios,Liapi Charis,Stripeli Fotini,Sklavos Pantelis,Margeli Alexandra,Christidou Aggeliki,Katsanika Aggeliki,Vogiatzakis Evangellos,Tzourmakliotis Dimitrios,Theocharis Stamatios

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/1471-230X-7-17/fulltext.html

Reference39 articles.

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Position cloning of the mouse obese gene and its human homologue. Nature. 1994, 372: 425-32. 10.1038/372425a0.

2. Spiegelman BM, Flier JS: Obesity and the regulation of energy balance. Cell. 2001, 104: 531-543. 10.1016/S0092-8674(01)00240-9.

3. Potter JJ, Womack L, Mezey E, Anania FA: Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun. 1998, 244: 178-182. 10.1006/bbrc.1997.8193.

4. Leclercq IA, Farrell GC, Schriemer R, Robertson GR: Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002, 37: 206-213. 10.1016/S0168-8278(02)00102-2.

5. Bethanis S, Theocharis S: Leptin in the field of hepatic fibrosis: a pivotal or incidental player?. Dig Dis Sci. 2006, 51: 1685-96. 10.1007/s10620-006-9126-0.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis;Frontiers in Gastroenterology;2024-01-24

2. Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation;Alimentary Pharmacology & Therapeutics;2022-11-21

3. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions;Journal of Hepatology;2022-07

4. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown;Frontiers in Endocrinology;2022-03-09

5. Exploiting the obesity-associated immune microenvironment for cancer therapeutics;Pharmacology & Therapeutics;2022-01